Is premenstrual dysphoric disorder a distinct clinical entity?

Jean Endicott, Jay Amsterdam, Elias Eriksson, Ellen Frank, Ellen Freeman, Robert Hirschfeld, Frank Ling, Barbara Parry, Teri Pearlstein, Jerrold Rosenbaum, David Rubinow, Peter Schmidt, Sally Severino, Meir Steiner, Donna E. Stewart, Susan Thys-Jacobs

Research output: Contribution to journalArticle

146 Scopus citations

Abstract

Does the evidence now available support the concept of premenstrual dysphoric disorder (PMDD) as a distinct clinical disorder such that the relative safety and efficacy of potential treatment can be evaluated? In a roundtable discussion of this question, a wealth of information was reviewed by a panel of experts. The key characteristics of PMDD, with clear onset and offset of symptoms closely linked to the menstrual cycle and the prominence of symptoms of anger, irritability, and internal tension, were contrasted with those of known mood and anxiety disorders. PMDD displays a distinct clinical picture that, in the absence of treatment, is remarkably stable from cycle to cycle and over time. Effective treatment of PMDD can be accomplished with serotinergic agents. At least 60% of patients respond to selective serotonin reuptake inhibitors (SSRIs). In comparison with other disorders, PMDD symptoms respond to low doses of SSRIs and to intermittent dosing. Normal functioning of the hypothalamic-pituitary-adrenal (HPA) axis, biologic characteristics generally related to the serotonin system, and a genetic component unrelated to major depression are further features of PMDD that separate it from other affective (mood) disorders. Based on this evidence, the consensus of the group was that PMDD is a distinct clinical entity. Potential treatments for this disorder can now be evaluated on this basis to meet the clear need for effective therapy.

Original languageEnglish (US)
Pages (from-to)663-679
Number of pages17
JournalJournal of Women's Health and Gender-Based Medicine
Volume8
Issue number5
StatePublished - Jun 1999

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Endicott, J., Amsterdam, J., Eriksson, E., Frank, E., Freeman, E., Hirschfeld, R., Ling, F., Parry, B., Pearlstein, T., Rosenbaum, J., Rubinow, D., Schmidt, P., Severino, S., Steiner, M., Stewart, D. E., & Thys-Jacobs, S. (1999). Is premenstrual dysphoric disorder a distinct clinical entity? Journal of Women's Health and Gender-Based Medicine, 8(5), 663-679.